DAVID STEFANSKY
CIK 1320581 · - · last filed 2023-08-21
DAVID STEFANSKY is a corporate insider who has filed 22 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing, for NXGLW, was dated Aug 21, 2023. Across all open-market trades the lifetime net is +$125.3K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $6.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$6.2K
2
22
$125.3K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NXGLW | Director | 228,663 | $0.03 | $6.2K | $125.3K | 10 | 2023-08-21 |
| Alliqua BioMedical, Inc. (ALQA) Delisted | Director | — | — | — | $0 | 1 | 2014-03-19 |
Recent Filings
22 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-08-21 | NXGLW | Grant (A) | — | $0 | EDGAR |
| 2023-06-09 | NXGLW | Buy (P) | +3,000 | $7.2K | EDGAR |
| 2023-06-01 | NXGLW | Buy (P) | +7,000 | $17.5K | EDGAR |
| 2022-12-19 | NXGLW | Buy (P) | +5,000 | $8.0K | EDGAR |
| 2022-12-13 | NXGLW | Buy (P) | +7,500 | $10.8K | EDGAR |
| 2022-08-31 | NXGLW | Buy (P) | +5,000 | $8.3K | EDGAR |
| 2022-08-26 | NXGLW | Buy (P) | +5,000 | $8.7K | EDGAR |
| 2022-08-17 | NXGLW | Buy (P) | +5,372 | $9.9K | EDGAR |
| 2022-06-27 | NXGLW | Buy (P) | +3,128 | $5.0K | EDGAR |
| 2022-01-03 | NXGLW | Mixed | +9,091 | $49.9K | EDGAR |